Mamessier Emilie, Song Joo Y, Eberle Franziska C, Pack Svetlana, Drevet Charlotte, Chetaille Bruno, Abdullaev Ziedulla, Adelaïde José, Birnbaum Daniel, Chaffanet Max, Pittaluga Stefania, Roulland Sandrine, Chott Andreas, Jaffe Elaine S, Nadel Bertrand
Haematologica. 2014 Mar;99(3):481-8. doi: 10.3324/haematol.2013.094474. Epub 2013 Oct 25.
The pathogenesis of follicular lymphoma is a multi-hit process progressing over many years through the accumulation of numerous genetic alterations. Besides the hallmark t(14;18), it is still unclear which other oncogenic hits contribute to the early steps of transformation and in which precursor stages these occur. To address this issue, we performed high-resolution comparative genomic hybridization microarrays on laser-capture micro-dissected cases of follicular lymphoma in situ (n=4), partial involvement by follicular lymphoma (n=4), and duodenal follicular lymphoma (n=4), assumed to represent, potentially, the earliest stages in the evolution of follicular lymphoma. Cases of reactive follicular hyperplasia (n=2), uninvolved areas from follicular lymphoma in situ lymph nodes, follicular lymphoma grade 1-2 (n=5) and follicular lymphoma grade 3A (n=5) were used as controls. Surprisingly, alterations involving several relevant (onco)genes were found in all entities, but at significantly lower proportions than in overt follicular lymphoma. While the number of alterations clearly assigns all these entities as precursors, the pattern of partial involvement by follicular lymphoma alterations was quantitatively and qualitatively closer to that of follicular lymphoma, indicating significant selective pressure in line with its faster rate of progression. Among the most notable alterations, we observed and validated deletions of 1p36 and gains of the 7p and 12q chromosomes and related oncogenes, which include some of the most recurrent oncogenic alterations in overt follicular lymphoma (TNFRSF14, EZH2, MLL2). By further delineating distinctive and hierarchical molecular and genetic features of early follicular lymphoma entities, our analysis underlines the importance of applying appropriate criteria for the differential diagnosis. It also provides a first set of candidates likely to be involved in the cascade of hits that pave the path of the various progression phases to follicular lymphoma development.
滤泡性淋巴瘤的发病机制是一个多步骤过程,多年来通过众多基因改变的积累而进展。除了标志性的t(14;18)外,目前仍不清楚还有哪些致癌性改变促成了转化的早期步骤以及这些改变发生在哪些前驱阶段。为了解决这个问题,我们对激光捕获显微切割的原位滤泡性淋巴瘤病例(n = 4)、滤泡性淋巴瘤部分累及病例(n = 4)和十二指肠滤泡性淋巴瘤病例(n = 4)进行了高分辨率比较基因组杂交微阵列分析,这些病例被认为可能代表滤泡性淋巴瘤演变的最早阶段。反应性滤泡增生病例(n = 2)、原位滤泡性淋巴瘤淋巴结未受累区域、1-2级滤泡性淋巴瘤(n = 5)和3A级滤泡性淋巴瘤(n = 5)用作对照。令人惊讶的是,在所有实体中均发现了涉及多个相关(致癌)基因的改变,但比例明显低于明显的滤泡性淋巴瘤。虽然改变的数量明确将所有这些实体归为前驱,但滤泡性淋巴瘤改变部分累及的模式在数量和质量上更接近滤泡性淋巴瘤,表明与其更快的进展速度一致的显著选择压力。在最显著的改变中,我们观察并验证了1p36的缺失以及7号和12号染色体及其相关致癌基因的增益,其中包括明显的滤泡性淋巴瘤中一些最常见的致癌性改变(TNFRSF14、EZH2、MLL2)。通过进一步描绘早期滤泡性淋巴瘤实体独特的分层分子和遗传特征,我们的分析强调了应用适当标准进行鉴别诊断的重要性。它还提供了可能参与一系列促成滤泡性淋巴瘤发展各个进展阶段的候选基因的第一组信息。